Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Hedge funds leveraging past successes to build new, unconstrained investment management firms

Monday, November 19, 2012

amb
Steve Diggle
Bailey McCann, Opalesque New York:

At its height, Artradis Fund Management grew to be one of the largest Asian hedge funds managing nearly $5bn. Now, that firm has transformed into something more closely resembling a family office, with some outside investment. The original team, including Steve Diggle, now manages the new iteration – Vulpes. Diggle recently spoke with Matthias Knab for Opalesque TV about why they made the transition and where they currently see new opportunities.

Artradis was originally a long Asian volatility fund. Diggle explains that after 2009, a lot of big name firms like AIG went short volatility and subsequently went out of business, as volatility prices increased, the upside to being long volatility became more muted driving Diggle and his team to look into other opportunities. Through Vulpes, the team expanded into five funds, including a broad range of investment types including private equity and physical assets.

The original long volatility fund still exists in addition to investments in public and private equity, a Russian investments fund and a life sciences fund. "One other thing that we have been doing that’s different is we have become more activist," Diggle says. He explains that as a pure hedge fund, the firm opted to stay away from that activist role, but now with investments in both public and private e......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its